Related Experiment Video

Updated: Aug 14, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 10, 2014

[Side effects after treatment with a-interferon in children with chronic viral hepatitis]

H Zhang1, X Yang, S Zhu

  • 1Department of Pediatric Hepatic Disease, the 302nd Hospital of PLA, Beijing 100039, China.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology
|July 27, 2001
PubMed

Insights

Alpha-interferon (IFN) treatment for chronic viral hepatitis in children is safe, with minimal early side effects compared to adults. Long-term observation revealed no lasting adverse effects, indicating its safety in pediatric patients.

Area of Science:

  • Hepatology
  • Pediatric Gastroenterology
  • Virology

Background:

  • Chronic viral hepatitis affects children, necessitating safe and effective treatments.
  • Alpha-interferon (IFN) is a therapeutic option, but its long-term safety profile in pediatric populations requires thorough investigation.

Purpose of the Study:

  • To conduct a long-term observation of side effects associated with alpha-IFN treatment in children diagnosed with chronic viral hepatitis.
  • To compare the incidence and severity of side effects in children versus adults receiving alpha-IFN therapy.

Main Methods:

  • A randomized trial involving 261 children treated with alpha-IFN (183 with hepatitis B, 78 with hepatitis C) and 114 adults.
  • Long-term follow-up, averaging 5-6 years and up to 10 years, to monitor for adverse events.
  • Assessment of early-stage and potential long-term side effects, including clinical symptoms and laboratory parameters (Serum Bil, Bun, Cr, T3, T4, TSH).

Main Results:

  • Children experienced significantly fewer early side effects, such as fever and influenza-like symptoms, compared to adults (P < 0.001).
  • Observed side effects in children, including mild appetite loss, hair thinning, rash, and tinnitus, were transient and required no specific treatment.
  • No correlation was found between side effects and viral etiology (hepatitis B or C) or disease severity (pathological changes G2 or G3).
  • All monitored laboratory parameters remained within normal ranges throughout the study.
  • Crucially, no long-term side effects were identified.

Conclusions:

  • Alpha-interferon (IFN) treatment is a safe therapeutic option for children with chronic viral hepatitis.
  • The favorable side effect profile in children supports the use of alpha-IFN in this demographic.
  • Long-term safety data indicates minimal risk associated with alpha-IFN therapy in pediatric viral hepatitis management.
Abstract

More Related Videos

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...